Drug and Alcohol Dependence
Volume 58, Issue 1 , Pages 67-75 , 1 February 2000

Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress

  • Kunio Yui

      Affiliations

    • Department of Psychiatry, Jichi Medical School, Minamikawachi, Tochigi 329-0498, Japan
    • Corresponding Author InformationCorresponding author. Present address: Takasago 3-16-34-31, Urawa 336-0011, Japan. Tel.: +81-48-8627520; Fax: +81-48-8361372
    • ,
  • Kimihiko Goto

      Affiliations

    • Oyama National College of Technology, Nakakiku, Tochigi 233-0806, Japan
    • ,
  • Shigenori Ikemoto

      Affiliations

    • Department of Legal Medicine and Human Genetics, Jichi Medical School, Minamikawachi, Tochigi 329-0498, Japan
    • ,
  • Takeo Ishiguro

      Affiliations

    • Department of Psychiatry, Jichi Medical School, Minamikawachi, Tochigi 329-0498, Japan

Received 19 January 1999 ,Revised 22 March 1999 ,Accepted 1 June 1999.

References 

  1. Abercrombie ED, Jacobs BL. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. 1. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 1987;7:2837–2843
  2. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. revised, American Psychiatric Association, Washington DC.
  3. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington DC.
  4. Bell DS. Comparison of amphetamine psychosis and schizophrenia. Br. J. Psychiatry. 1965;111:701–707
  5. Breier A, Buchanan RW, Waltrip II RW, Listwak S, Holmes C, Goldstein DS. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology. 1994;10:1–7
  6. Cahill L, Prins B, Weber M, McGaugh JL. β-adrenergic activation and memory for emotional events. Nature. 1994;371:702–704
  7. Castellani S, Ziegler MG, van Kammen DP, Alexander PE, Siris SG, Lake CR. Plasma norepinephrine and dopamine-β-hydroxylase activity in schizophrenia. Arch. Gen. Psychiatry. 1982;39:1145–1149
  8. Charpusta SJ, Wyatt RJ, Masserano JM. Effects of single and repeated footshock on dopamine release and metabolism in the brains of fisher rats. J. Neurochem. 1997;68:2024–2031
  9. Cumming P, Brown E, Damsma G, Fibiger H. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study. J. Neurochem. 1992;59:1905–1914
  10. Deegan R, He HG, Wood AJJ, Wood M. Effects of anesthesia on norepinephrine kinetics. Anesthesiology. 1991;75:481–488
  11. Dimsdale JE, Moss J. Plasma catecholamines in stress and exercise. JAMA. 1980;243:340–342
  12. Goldstein DS, Eisenhofer G, Sax FL, Keiser HR, Kopin IR. Plasma norepinephrine pharmacokinetics during mental challenge. Psychosom. Med. 1987;49:591–605
  13. Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, et al. Haloperidol response and plasma catecholamines and their metabolites. Schizophr. Res. 1993;10:33–37
  14. Hausner RS. Amantadine-associated recurrence of psychosis. Am. J. Psychiatry. 1980;137:240–242
  15. Havilcek LL, Crain RD. Practical Statistics for Physical Sciences. Washington DC: American Chemical Society; 1988;
  16. Heal DJ, Frankland ATJ, Buckett WR. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detention studies with drugs which alter dopamine metabolism in the brain. Neuropharmacology. 1990;29:1141–1150
  17. Irwin J, Ahiluwalia P, Anisman H. Sensitization of norepinephrine activity following acute and chronic footshock. Brain Res. 1986;379:98–103
  18. Kent AP, Stern GM, Webster RA. The effect of benserazide on the peripheral and central distribution and metabolism of lovodopa after acute and chronic administration in the rat. Br. J. Pharmacol. 1990;100:743–748
  19. Landau SI. International Dictionary of Medicine and Biology. III. New York, Chichester, Brisbane, Toronto, Singapore: A Wiley Medical Publication; 1986;
  20. Matefy RE, Hayes C, Hirsh J. Psychedelic drug flashbacks: subjective reports and biographical data. Addictive Behav. 1978;3:165–178
  21. Millns H, Woodward M, Bolton-Smith C. Is it necessary to transform nutrient variables prior to statistical analyses?. Am. J. Epidemiol. 1995;141:251–262
  22. Ohashi H. Prison health issues: agenda item 2, the 15th Asian and Pacific Conference of Correctional Administrators (in Japanese). Jpn J. Correct. 1996;107:36–46
  23. Ozawa A. Normal and abnormal values: catecholamines (in Japanese). Sogorinsho (Gen. Pract. Med.). 1991;40:1332–1338
  24. Péronnet F, Blier P, Brisson G, Diamond P, Ledoux M, Volle M. Plasma catecholamines at rest and exercise in subjects with high- and low-trait anxiety. Psychosom. Med. 1986;48:52–58
  25. Petty F, Chae Y-I, Kramer C, Jordan S, Wilson L. Learned helplessness sensitizes hippocampal norepinephrine to mild restress. Biol. Psychiatry. 1994;35:903–908
  26. Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, et al. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Arch. Gen. Psychiatry. 1986;43:669–676
  27. Risbo A, Jessen K, Hagelsten JO. Catecholamine response to the clinical use of alpha adrenergic receptor blocking agents. Acta Anaesthesiol. Scand. 1983;27:72–74
  28. Robinson TE, Becker JB, Young EA, Akil H, Castaneda E. The effects of footshock stress on regional brain dopamine metabolism and pituitary β-endorphin release in rats previously sensitized to amphetamine. Neuropharmacology. 1986;26:679–691
  29. Roy A, Pickar D, Jong JD, Karoum F, Linnoila M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Arch. Gen. Psychiatry. 1988;45:849–857
  30. Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A, et al. Abnormal noradrenergic function in post-traumatic stress disorder. Arch. Gen. Psychiatry. 1993;50:266–274
  31. Spielberger CD. Manual for the State–Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologist Press; 1983;
  32. Tuck JR. Effects of chlorpromazine, thioridazine and haloperidol on adrenergic transmitter mechanisms in man. Eur. J. Clin. Pharmacol. 1973;6:81–87
  33. Utena H. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlations in the brain. Prog. Brain Res. 1966;21B:192–207
  34. van Valkenburg C, van der Krogt J, Moleman P, van Berkum H, Tjaden U, de Jong J. A procedure to measure the specific activities of dopamine and its metabolites in rat striatum, based on HPLC, electrochemical detection and liquid scintillation counting. J. Neurosci. Meth. 1984;11:29–38
  35. Wang MT, Yoshioka M, Imai K, Tamura Z. Gas-liquid chromatographic and mass fragmentographic determination of 3-O-methylated catecholamines in human plasma. Clin. Chim. Acta. 1975;63:21–27
  36. Westerink BHC, Spaan SJ. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain. J. Neurochem. 1982;38:680–686
  37. Wood PL, Altar CA. Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons utility of 3-methoxytyramine measurements. Pharmacol. Rev. 1988;40:163–187
  38. Yui K, Goto K, Ikemoto S, Ishiguro T. Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks. Psychiatr. Res. 1996;63:93–107
  39. Yui K, Goto K, Ishiguro T, Ikemoto S. Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis. Drug Alcohol Depend. 1997;44:183–187

☆ Institute at which the work was carried out: Department of Legal Medicine and Human Genetics, Jichi Medical School, Minamikawachi, Tochigi 329-0431, and Medical Care Section, Tochigi Prison, Ministry of Justice, Sozya 2484, Tochigi 328-0002, Japan.

PII: S0376-8716(99)00060-5

Drug and Alcohol Dependence
Volume 58, Issue 1 , Pages 67-75 , 1 February 2000

Article Tools